{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:56:15Z","timestamp":1758048975217,"version":"3.44.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bcp.2020.114101","type":"journal-article","created":{"date-parts":[[2020,6,14]],"date-time":"2020-06-14T09:36:13Z","timestamp":1592127373000},"page":"114101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Exhaled nitric oxide and its predictive power related to lung function and bronchial inflammation"],"prefix":"10.1016","volume":"179","author":[{"given":"Alain","family":"Van Muylem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Malinovschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaryllis","family":"Haccuria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Michils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114101_b0005","unstructured":"Global Initiative for Asthma. Available from: www.ginasthma.org."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri3786","article-title":"Type 2 inflammation in asthma\u2013present in most, absent in many","volume":"15","author":"Fahy","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0025","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00938-2018","article-title":"\u201cT2-high\u201d in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin","volume":"53","author":"Pavlidis","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.bcp.2020.114101_b0030","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","author":"American Thoracic","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"12","key":"10.1016\/j.bcp.2020.114101_b0040","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2018-211540","article-title":"Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis","volume":"73","author":"Petsky","year":"2018","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.bcp.2020.114101_b0045","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/cea.12749","article-title":"Important non-disease-related determinants of exhaled nitric oxide levels in mild asthma - results from the Swedish GA(2) LEN study","volume":"46","author":"Al-Shamkhi","year":"2016","journal-title":"Clin. Exp. Allergy"},{"issue":"24","key":"10.1016\/j.bcp.2020.114101_b0050","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1152\/physrev.00034.2003","article-title":"Nitric oxide in health and disease of the respiratory system","volume":"84","author":"Ricciardolo","year":"2004","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.bcp.2020.114101_b0060","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nrmicro1004","article-title":"Antimicrobial reactive oxygen and nitrogen species: concepts and controversies","volume":"2","author":"Fang","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"17","key":"10.1016\/j.bcp.2020.114101_b0065","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.92.17.7809","article-title":"Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo","volume":"92","author":"Guo","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.bcp.2020.114101_b0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/thx.2003.014894","article-title":"Epithelial inducible nitric oxide synthase activity is the major determinant of nitric oxide concentration in exhaled breath","volume":"59","author":"Lane","year":"2004","journal-title":"Thorax"},{"issue":"Suppl 5","key":"10.1016\/j.bcp.2020.114101_b0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1289\/ehp.98106s51119","article-title":"Characterization of inducible nitric oxide synthase expression in human airway epithelium","volume":"106","author":"Guo","year":"1998","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0080","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1165\/rcmb.2006-0419OC","article-title":"Measurement of IL-13-induced iNOS-derived gas phase nitric oxide in human bronchial epithelial cells","volume":"37","author":"Suresh","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.bcp.2020.114101_b0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nm.3300","article-title":"Eosinophils in the spotlight: Eosinophilic airway inflammation in nonallergic asthma","volume":"19","author":"Brusselle","year":"2013","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bcp.2020.114101_b0090","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/j.1365-2222.2005.02314.x","article-title":"The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma","volume":"35","author":"Berry","year":"2005","journal-title":"Clin. Exp. Allergy"},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1067\/mai.2000.109622","article-title":"A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation","volume":"106","author":"Berlyne","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.53.2.91","article-title":"Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma","volume":"53","author":"Jatakanon","year":"1998","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/rccm.200610-1427OC","article-title":"The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial","volume":"176","author":"Shaw","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0110","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2006.08.003","article-title":"Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes","volume":"118","author":"Lemiere","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8886\u20138887","key":"10.1016\/j.bcp.2020.114101_b0115","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(05)80083-2","article-title":"Induction of nitric oxide synthase in asthma","volume":"342","author":"Hamid","year":"1993","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.bcp.2020.114101_b0120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2222.2008.02969.x","article-title":"IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells","volume":"38","author":"Chibana","year":"2008","journal-title":"Clin. Exp. Allergy"},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0125","doi-asserted-by":"crossref","first-page":"e90018","DOI":"10.1371\/journal.pone.0090018","article-title":"Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS","volume":"9","author":"Roos","year":"2014","journal-title":"PLoS ONE"},{"issue":"9842","key":"10.1016\/j.bcp.2020.114101_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0140-6736(12)60988-X","article-title":"Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial","volume":"380","author":"Pavord","year":"2012","journal-title":"Lancet"},{"issue":"10039","key":"10.1016\/j.bcp.2020.114101_b0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bcp.2020.114101_b0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in Adults with Uncontrolled Asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0145","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jaci.2013.07.045","article-title":"Exhaled nitric oxide and blood eosinophilia: independent markers of preventable risk","volume":"132","author":"Pavord","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0150","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bcp.2020.114101_b0155","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.alit.2018.04.003","article-title":"Implication of fraction of exhaled nitric oxide and blood eosinophil count in severe asthma","volume":"67S","author":"Soma","year":"2018","journal-title":"Allergol. Int."},{"issue":"9","key":"10.1016\/j.bcp.2020.114101_b0160","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.93.06091368","article-title":"Increased amount of nitric oxide in exhaled air of asthmatics","volume":"6","author":"Alving","year":"1993","journal-title":"Eur. Respir. J."},{"issue":"8890","key":"10.1016\/j.bcp.2020.114101_b0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(94)90931-8","article-title":"Increased nitric oxide in exhaled air of asthmatic patients","volume":"343","author":"Kharitonov","year":"1994","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0170","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.02.00285302","article-title":"Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship","volume":"20","author":"Jones","year":"2002","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0175","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/rccm.200310-1376OC","article-title":"Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests","volume":"169","author":"Smith","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/thoraxjnl-2016-208704","article-title":"Accuracy of FENO for diagnosing asthma: a systematic review","volume":"72","author":"Karrasch","year":"2017","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.mayocp.2017.11.012","article-title":"The diagnostic accuracy of fractional exhaled nitric oxide testing in asthma: a systematic review and meta-analyses","volume":"93","author":"Wang","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bcp.2020.114101_b0195","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.rmed.2019.07.010","article-title":"Scottish consensus statement on the role of FeNO in adult asthma","volume":"155","author":"Kuo","year":"2019","journal-title":"Respir. Med."},{"key":"10.1016\/j.bcp.2020.114101_b0200","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.niox.2014.06.009","article-title":"FeNO as a predictor of asthma control improvement after starting inhaled steroid treatment","volume":"40","author":"Malinovschi","year":"2014","journal-title":"Nitric Oxide"},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S2213-2600(17)30424-1","article-title":"Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Respir Med."},{"issue":"11","key":"10.1016\/j.bcp.2020.114101_b0210","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1164\/rccm.201204-0587OC","article-title":"The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma","volume":"186","author":"McNicholl","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0215","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/rccm.201806-1182OC","article-title":"Remotely monitored therapy and nitric oxide suppression identifies nonadherence in severe asthma","volume":"199","author":"Heaney","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"8","key":"10.1016\/j.bcp.2020.114101_b0220","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2020.114101_b0225","doi-asserted-by":"crossref","DOI":"10.1177\/1753466619841274","article-title":"Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study","volume":"13","author":"Solidoro","year":"2019","journal-title":"Ther. Adv. Respir. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0230","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00936-2018","article-title":"Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma","volume":"52","author":"Bleecker","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.bcp.2020.114101_b0235","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(14)70201-2","article-title":"Benralizumab, an anti-interleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study","volume":"2","author":"Castro","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.bcp.2020.114101_b0240","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/ACI.0b013e32834c3d30","article-title":"Anti-interleukin-5 antibody therapy in asthma and allergies","volume":"11","author":"Corren","year":"2011","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"issue":"26","key":"10.1016\/j.bcp.2020.114101_b0245","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.bcp.2020.114101_b0250","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.bcp.2020.114101_b0255","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0260","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1164\/ajrccm.164.5.2012125","article-title":"The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control","volume":"164","author":"Jones","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1183\/09031936.00020407","article-title":"Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients","volume":"31","author":"Michils","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1164\/ajrccm.161.1.9809100","article-title":"Changes in sputum eosinophils predict loss of asthma control","volume":"161","author":"Jatakanon","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0275","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/ajrccm.163.2.9912091","article-title":"Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids","volume":"163","author":"Leuppi","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0280","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/thx.51.3.233","article-title":"Exhaled nitric oxide: a new lung function test","volume":"51","author":"Barnes","year":"1996","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0285","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1183\/09031936.00135907","article-title":"Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma","volume":"32","author":"van Veen","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"3 Pt 1","key":"10.1016\/j.bcp.2020.114101_b0290","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/ajrccm.157.3.9709064","article-title":"Exhaled nitric oxide correlates with airway hyperresponsiveness in steroid-naive patients with mild asthma","volume":"157","author":"Dupont","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.bcp.2020.114101_b0295","article-title":"Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge","volume":"113981","author":"Bougard","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2020.114101_b0300","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/ajrccm.158.1.9703005","article-title":"Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma","volume":"158","author":"de Gouw","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.bcp.2020.114101_b0305","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1034\/j.1399-3003.2000.01506.x","article-title":"The current single exhalation method of measuring exhales nitric oxide is affected by airway calibre","volume":"15","author":"Ho","year":"2000","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0310","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1152\/japplphysiol.00530.2017","article-title":"A new role for the exhaled nitric oxide as a functional marker of peripheral airway caliber changes: a theoretical study","volume":"124","author":"Karamaoun","year":"2018","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0315","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1152\/japplphysiol.01401.2010","article-title":"Adenosine 5'-monophosphate challenge elicits a more peripheral airway response than methacholine challenge","volume":"110","author":"Michils","year":"2011","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0320","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.resp.2012.09.011","article-title":"Axial distribution of nitric oxide airway production in asthma patients","volume":"185","author":"Van Muylem","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0325","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/ajrccm.160.2.9809130","article-title":"Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation","volume":"160","author":"Gauvreau","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.bcp.2020.114101_b0330","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaci.2013.08.023","article-title":"Inhaled allergen bronchoprovocation tests","volume":"132","author":"Diamant","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0335","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jaci.2013.12.1070","article-title":"Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes","volume":"134","author":"Haccuria","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2020.114101_b0340","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00392-2017","article-title":"Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control","volume":"50","author":"Michils","year":"2017","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0345","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2015.09.054","article-title":"Different patterns of exhaled nitric oxide response to beta2-agonists in asthmatic patients according to the site of bronchodilation","volume":"137","author":"Michils","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2020.114101_b0350","doi-asserted-by":"crossref","first-page":"036002","DOI":"10.1088\/1752-7163\/ab0a14","article-title":"COPD patients with peripheral airway obstruction reversibility identified by exhaled nitric oxide","volume":"13","author":"Perez-Bogerd","year":"2019","journal-title":"J. Breath Res."},{"issue":"4","key":"10.1016\/j.bcp.2020.114101_b0355","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1152\/japplphysiol.01032.2007","article-title":"Airway contribution to alveolar nitric oxide in healthy subjects and stable asthma patients","volume":"104","author":"Kerckx","year":"2008","journal-title":"J. Appl. Physiol. (1985)"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295220303373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:11:59Z","timestamp":1757769119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295220303373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":71,"alternative-id":["S0006295220303373"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114101","relation":{},"ISSN":["0006-2952"],"issn-type":[{"type":"print","value":"0006-2952"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exhaled nitric oxide and its predictive power related to lung function and bronchial inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114101","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114101"}}